Join Phillips Medisize at the PDA Japan Conference 2025, September 17–18, in Tokyo.
On September 17, 2:10–2:50 JST, Dr. Geraldine Venthoye, Chief Scientific Officer & EVP, will present “Key Considerations When Repositioning from Parenteral to Inhaled Drug Administration.”
Visit us at PDA Japan to learn about our parenteral drug delivery device innovations and regional manufacturing site capabilities.
Our Platform Products
Phillips Medisize offers customizable platform products to accelerate development timelines, help reduce risk and enhance cost efficiencies. Leverage Phillips Medisize’s platform products to tap into our world-class engineering expertise; our platform products are designed to meet your specific needs.
We apply award-winning solutions to solve complex engineering challenges through investment in new technologies, all while keeping your business goals front and center.
Want to Meet Now?
Questions? To schedule a meeting with one of our subject-matter experts, please fill out the Contact Us form and we will follow up with you.